• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生发中心T辅助细胞标志物PD-1和CXCL13在血管免疫母细胞性T细胞淋巴瘤的肿瘤细胞中均有表达。

Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma.

作者信息

Yu Hongbo, Shahsafaei Aliakbar, Dorfman David M

机构信息

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

出版信息

Am J Clin Pathol. 2009 Jan;131(1):33-41. doi: 10.1309/AJCP62WRKERPXDRT.

DOI:10.1309/AJCP62WRKERPXDRT
PMID:19095563
Abstract

Gene expression profiling identified genes uniquely expressed by human germinal-center T-helper (GCTh) cells, including programmed death-1 (PD-1) and CXCL13. Recently, we demonstrated that PD-1 is an immunophenotypic marker of GCTh cells and angioimmunoblastic T-cell lymphoma (AITL). The goal of this study was to investigate the expression pattern of CXCL13 in comparison with PD-1. We studied 63 cases of T-cell lymphoproliferative disorders, including 22 cases of AITL. In cases of AITL, PD-1+ and CXCL13+ neoplastic cells were seen at foci of expanded CD21+ follicular dendritic cell networks. CXCL13 expression was limited in other peripheral T-cell lymphomas. PD-1 and CXCL13 identified germinal-center T-helper cells, showed a similar pattern of expression in AITL, and should serve as useful new markers for AITL. The similar pattern of expression of CXCL13 and PD-1 in AITL provides further evidence that AITL is a neoplasm derived from germinal-center T-helper cells.

摘要

基因表达谱分析鉴定出了人类生发中心辅助性T细胞(GCTh)独特表达的基因,包括程序性死亡受体1(PD-1)和CXC趋化因子配体13(CXCL13)。最近,我们证明PD-1是GCTh细胞和血管免疫母细胞性T细胞淋巴瘤(AITL)的免疫表型标志物。本研究的目的是比较CXCL13与PD-1的表达模式。我们研究了63例T细胞增殖性疾病,其中包括22例AITL。在AITL病例中,在扩大的CD21+滤泡树突状细胞网络区域可见PD-1+和CXCL13+肿瘤细胞。CXCL13在其他外周T细胞淋巴瘤中的表达有限。PD-1和CXCL13可识别生发中心辅助性T细胞,在AITL中显示出相似的表达模式,应作为AITL有用的新标志物。CXCL13和PD-1在AITL中相似的表达模式进一步证明AITL是一种源自生发中心辅助性T细胞的肿瘤。

相似文献

1
Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma.生发中心T辅助细胞标志物PD-1和CXCL13在血管免疫母细胞性T细胞淋巴瘤的肿瘤细胞中均有表达。
Am J Clin Pathol. 2009 Jan;131(1):33-41. doi: 10.1309/AJCP62WRKERPXDRT.
2
Peripheral T-cell lymphoma with follicular T-cell markers.伴有滤泡性T细胞标志物的外周T细胞淋巴瘤
Am J Surg Pathol. 2008 Dec;32(12):1787-99. doi: 10.1097/PAS.0b013e31817f123e.
3
CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T-cell lymphoma.CD200(OX-2 膜糖蛋白)表达于滤泡辅助性 T 细胞,也见于血管免疫母细胞性 T 细胞淋巴瘤。
Am J Surg Pathol. 2011 Jan;35(1):76-83. doi: 10.1097/PAS.0b013e31820065c9.
4
A case report of angioimmunoblastic T cell lymphoma (AITL) with localization of neoplastic clear cells in the outer zone of germinal centers.生发中心外区瘤细胞呈透明细胞样定位的血管免疫母细胞 T 细胞淋巴瘤(AITL)1 例报告。
Pathol Int. 2011 May;61(5):322-5. doi: 10.1111/j.1440-1827.2011.02655.x. Epub 2011 Apr 4.
5
Expression of follicular helper T cell markers in nodal peripheral T cell lymphomas: a tissue microarray analysis of 162 cases.滤泡辅助性 T 细胞标志物在结外周围 T 细胞淋巴瘤中的表达:162 例组织微阵列分析。
J Clin Pathol. 2011 Apr;64(4):319-24. doi: 10.1136/jcp.2010.084459. Epub 2011 Feb 17.
6
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation.诱导型 T 细胞共刺激分子表达于 T 细胞亚群上,是滤泡辅助性 T 细胞来源的淋巴瘤的一个新的标志物。
Haematologica. 2010 Mar;95(3):432-9. doi: 10.3324/haematol.2009.010991.
7
[Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma].血管免疫母细胞性T细胞淋巴瘤的形态学及免疫表型分析
Zhonghua Bing Li Xue Za Zhi. 2009 Mar;38(3):173-7.
8
Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma.血管免疫母细胞性T细胞淋巴瘤中生发中心T细胞的两种标志物(SAP和PD-1)的表达情况
Haematologica. 2007 Aug;92(8):1059-66. doi: 10.3324/haematol.10864. Epub 2007 Jul 20.
9
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.程序性死亡蛋白1(PD-1)是生发中心相关T细胞和血管免疫母细胞性T细胞淋巴瘤的标志物。
Am J Surg Pathol. 2006 Jul;30(7):802-10. doi: 10.1097/01.pas.0000209855.28282.ce.
10
[Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].CXCL13、CD10和bcl-6在血管免疫母细胞性T细胞淋巴瘤及外周T细胞淋巴瘤(非特殊类型)中的表达
Zhonghua Bing Li Xue Za Zhi. 2009 Apr;38(4):224-30.

引用本文的文献

1
scRNA-seq reveals the landscape of immune repertoire of PBMNCs in iMCD.单细胞 RNA 测序揭示 iMCD 中 PBMNCs 免疫受体库的全景。
Oncogene. 2024 Sep;43(37):2795-2805. doi: 10.1038/s41388-024-03128-8. Epub 2024 Aug 15.
2
Role and application of chemokine CXCL13 in central nervous system lymphoma.趋化因子 CXCL13 在中枢神经系统淋巴瘤中的作用及应用。
Ann Hematol. 2024 Aug;103(8):2671-2680. doi: 10.1007/s00277-023-05560-4. Epub 2023 Nov 27.
3
SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.
SOHO 最新进展与未来展望 | 探讨新途径与新靶点,以实现 PTCL 精准治疗:稳扎稳打。
Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):561-574. doi: 10.1016/j.clml.2023.04.007. Epub 2023 Apr 19.
4
Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment.伴有主要 CD8+肿瘤浸润 T 细胞的血管免疫母细胞性 T 细胞淋巴瘤是一种具有免疫抑制微环境的独特免疫模式。
Front Immunol. 2022 Oct 17;13:987227. doi: 10.3389/fimmu.2022.987227. eCollection 2022.
5
Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors.免疫检查点调节剂、程序性死亡配体 1(PD-L1/PD-1)、细胞毒性 T 淋巴细胞抗原 4(CTLA-4)和吲哚胺-2,3-双加氧酶(IDO)在子宫间质肿瘤中的表达。
Diagn Pathol. 2022 Sep 14;17(1):70. doi: 10.1186/s13000-022-01251-2.
6
The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease.局灶型和特发性多中心 Castleman 病的淋巴结转录组。
Haematologica. 2023 Jan 1;108(1):207-218. doi: 10.3324/haematol.2021.280370.
7
Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?肿瘤微组织工程时代的黑色素瘤免疫疗法与精准医学:我们现在何处,又将去往何方?
Cancers (Basel). 2021 Nov 18;13(22):5788. doi: 10.3390/cancers13225788.
8
CXCL13 Signaling in the Tumor Microenvironment.CXCL13 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1302:71-90. doi: 10.1007/978-3-030-62658-7_6.
9
Expression of the checkpoint receptors LAG-3, TIM-3 and VISTA in peripheral T cell lymphomas.外周 T 细胞淋巴瘤中检查点受体 LAG-3、TIM-3 和 VISTA 的表达。
J Clin Pathol. 2020 Apr;73(4):197-203. doi: 10.1136/jclinpath-2019-206117. Epub 2019 Oct 31.
10
GATA-3 in T-cell lymphoproliferative disorders.GATA-3 在 T 细胞淋巴增生性疾病中的作用。
IUBMB Life. 2020 Jan;72(1):170-177. doi: 10.1002/iub.2130. Epub 2019 Jul 17.